SCOPUS 정보 검색 플랫폼

Volumn 359, Issue 9315, 2002, Pages 1379-1387

Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: The LIPID trial follow-up

(13) Simes, R John a,b Hunt, D b Kirby, A b Tonkin, A b Keech, A b Aylward, P b Colquhoun, D b Glasziou, P b Hague, W b MacMahon, S b Thompson, P b West, M b White, H b

a UNIVERSITY OF SYDNEY (Australia)

b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; PLACEBO; PRAVASTATIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HEART INFARCTION; HORMONE DETERMINATION; HUMAN; ISCHEMIC HEART DISEASE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORALITY; PRIORITY JOURNAL; RISK ASSESSMENT; STROKE; TIME; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

EID: 0037140177 PISSN: 01406736 EISSN: None Source Type: Journal
DOI: 10.1016/S0140-6736(02)08351-4 Document Type: Article

Times cited : (247)

References (28)

1
- 0027987849
- Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
- Lancet
- (1994) Lancet , vol.344 , pp. 1383-1389

2
- 0342981862
- The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
- N Engl J Med
- (1996) N Engl J Med , vol.335 , pp. 1001-1009
- Sacks, F.M.¹ Pfeffer, M.A.² Moye, L.A.³

3
- 0032487931
- Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
- N Engl J Med
- (1998) N Engl J Med , vol.339 , pp. 1349-1357

4
- 0029074865
- Design features and baseline characteristics of the LIPID (Long-term Intervention with Pravastatin in Ischaemic Disease) study: A randomised trial in patients with previous acute myocardial infarction and/or unstable angina pectoris
- Am J Cardiol
- (1995) Am J Cardiol , vol.76 , pp. 474-479

5
- 0034964438
- Long-term risk stratification for survivors of acute coronary syndromes: Results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study
- J Am Coll Cardiol
- (2001) J Am Coll Cardiol , vol.38 , pp. 56-63
- Marschner, I.C.¹ Colquhoun, D.² Simes, R.J.³

6
- 85123744069
- Cholesterol-lowering therapy with pravastatin in patients with average cholesterol levels and established ischaemic heart disease: Is it cost-effective?
- in press
- Med J Aust
- Med J Aust
- Glasziou, P.¹ Mulray, S.² Simes, S.³

7
- 0036488096
- Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels: The Prospective Pravastatin Pooling project
- Eur Heart J
- (2002) Eur Heart J , vol.23 , pp. 207-215
- Simes, R.J.¹ Furberg, C.D.² Braunwald, E.³

8
- 0023001772
- Fifteen-year mortality in coronary drug project patients: Long-term benefit with niacin
- J Am Coll Cardiol
- (1986) J Am Coll Cardiol , vol.8 , pp. 1245-1255
- Canner, P.L.¹ Berge, K.G.² Wenger, N.K.³ Stamler, J.⁴ Friedewald, W.⁵

9
- 0033914187
- Follow-up study of patients randomised in the Scandinavian Simvastatin Survival Study (4S) of cholesterol lowering
- Am J Cardiol
- (2000) Am J Cardiol , vol.86 , pp. 257-262
- Pedersen, T.R.¹ Wilhelmsen, L.² Faergeman, O.³

10
- 0029931157
- Cost of prevention. The case of lipid lowering
- Circulation
- (1996) Circulation , vol.93 , pp. 1774-1776
- Yusuf, S.¹ Anand, S.²

11
- 0032572043
- Antiatherothrombotic properties of statins. Implications for cardiovascular event reduction
- JAMA
- (1998) JAMA , vol.279 , pp. 1643-1650
- Rosenson, R.S.¹ Tangney, C.C.²

12
- 0035804846
- Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes - The MIRACL study: A randomized controlled trial
- JAMA
- (2001) JAMA , vol.285 , pp. 1711-1718
- Schwartz, G.G.¹ Olsson, A.G.² Ezekowitz, M.D.³

13
- 0028845911
- Reduction in cardiovascular events during pravastatin therapy - Pooled analysis of clinical events of the Pravastatin Atherosclerosis Intervention Program
- Circulation
- (1995) Circulation , vol.92 , pp. 2419-2425
- Byington, R.P.¹ Jukema, J.W.² Salonen, J.T.³

14
- 0033786342
- Statins and cardiovascular diseases: The multiple effects of lipid-lowering therapy by statins
- Atherosclerosis
- (2000) Atherosclerosis , vol.153 , pp. 181-189
- Rauch, U.¹ Osende, J.I.² Chesebro, J.H.³

15
- 85123744017
- Relationship between lipid effects and clinical outcomes in the LIPID trial: To what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?
- Circulation
- (2002) Circulation , vol.105 , pp. 116-129
- Simes, R.J.¹ Marschner, I.C.² Hunt, D.³ Tonkin, A.⁴

16
- 0034680352
- The effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: The Prospective Pravastatin Pooling project
- Circulation
- (2000) Circulation , vol.102 , pp. 1895-1900
- Sacks, F.M.¹ Tonkin, A.M.² Shepherd, J.³

17
- 0036156342
- The MRC/BHF Heart Protection Study: Preliminary results
- Int J Clin Pr
- (2002) Int J Clin Pr , vol.56 , pp. 53-56
- Collins, R.¹ Peto, R.² Armitage, J.³ Owen, O.G.⁴

18
- 0034601425
- Pravastatin therapy and the risk of stroke
- N Engl J Med
- (2000) N Engl J Med , vol.343 , pp. 317-326
- White, H.D.¹ Simes, R.J.² Anderson, N.E.³

19
- 0026195827
- Low serum cholesterol and the risk of cancer: An analysis of the published prospective studies
- Cancer Causes Control
- (1991) Cancer Causes Control , vol.2 , pp. 253-261
- Law, M.R.¹ Thompson, S.G.²

20
- 0025345588
- London: BMJ Publishing
- Lowering cholesterol concentrations and mortality: A quantitative review of primary prevention trials
- (1990) Lowering cholesterol concentrations and mortality: A quantitative review of primary prevention trials , pp. 309-314
- Muldoon, M.F.¹ Manuck, S.B.² Matthews, K.A.³

21
- 0035876762
- Do statins cause cancer? A meta-analysis of large randomised clinical trials
- Am J Med
- (2001) Am J Med , vol.110 , pp. 716-723
- Bjerre, L.M.¹ LeLorier, J.²

22
- 85044706316
- A European Society of Cardiology survey of secondary prevention of coronary heart disease: Principal results
- Eur Heart J
- (1997) Eur Heart J , vol.18 , pp. 1569-1582

23
- 0033594179
- Use of aspirin, beta-blockers, and lipid-lowering medications before recurrent acute myocardial infarction: Missed opportunities for prevention?
- Arch Intern Med
- (1999) Arch Intern Med , vol.159 , pp. 561-567
- McCormick, D.¹ Gurwitz, J.H.² Lessard, D.³

24
- 0035978089
- Clinical reality of coronary prevention guidelines: A comparison of EUROASPIRE I and II in nine countries
- Lancet
- (2001) Lancet , vol.357 , pp. 995-1001
- Kotseva, K.¹ Wood, D.² De Backer, G.³

25
- 0001791553
- Hypercholesterolaemia as a risk factor for coronary heart disease in the Asia-Pacific region: The ASPAC study
- Atherosclerosis
- (2000) Atherosclerosis , vol.151 , pp. 83
- Keech, A.¹ Zambahari, R.² Ritchie, G.³ Kalim, H.⁴

26
- 0032513736
- Persistence of use of lipid-lowering medications: A cross-national study
- JAMA
- (1998) JAMA , vol.279 , pp. 1458-1462
- Avorn, J.¹ Monette, J.² Lacour, A.³

27
- 0030044261
- Apparent discontinuation rates in patients prescribed lipid lowering drugs
- Med J Aust
- (1996) Med J Aust , vol.164 , pp. 208-211
- Simons, L.A.¹ Levis, G.² Simons, J.³

28
- 0030983708
- Mortality by cause for eight regions of the world: Global Burden of Disease Study
- Lancet
- (1997) Lancet , vol.349 , pp. 1269-1276
- Murray, C.J.L.¹ Lopez, A.D.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.